Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105


Frequency of MRI changes suggestive of axial spondyloarthritis in the axial skeleton in a large population-based cohort of individuals aged <45 years.

Baraliakos X, Richter A, Feldmann D, Ott A, Buelow R, Schmidt CO, Braun J.

Ann Rheum Dis. 2019 Nov 19. pii: annrheumdis-2019-215553. doi: 10.1136/annrheumdis-2019-215553. [Epub ahead of print]


Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies.

Trinklein ND, Pham D, Schellenberger U, Buelow B, Boudreau A, Choudhry P, Clarke SC, Dang K, Harris KE, Iyer S, Jorgensen B, Pratap PP, Rangaswamy US, Ugamraj HS, Vafa O, Wiita AP, van Schooten W, Buelow R, Force Aldred S.

MAbs. 2019 May/Jun;11(4):639-652. doi: 10.1080/19420862.2019.1574521. Epub 2019 Feb 20.


Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies.

Clarke SC, Ma B, Trinklein ND, Schellenberger U, Osborn MJ, Ouisse LH, Boudreau A, Davison LM, Harris KE, Ugamraj HS, Balasubramani A, Dang KH, Jorgensen B, Ogana HAN, Pham DT, Pratap PP, Sankaran P, Anegon I, van Schooten WC, Brüggemann M, Buelow R, Force Aldred S.

Front Immunol. 2019 Jan 7;9:3037. doi: 10.3389/fimmu.2018.03037. eCollection 2018.


Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific Antibodies.

Harris KE, Aldred SF, Davison LM, Ogana HAN, Boudreau A, Brüggemann M, Osborn M, Ma B, Buelow B, Clarke SC, Dang KH, Iyer S, Jorgensen B, Pham DT, Pratap PP, Rangaswamy US, Schellenberger U, van Schooten WC, Ugamraj HS, Vafa O, Buelow R, Trinklein ND.

Front Immunol. 2018 Apr 24;9:889. doi: 10.3389/fimmu.2018.00889. eCollection 2018.


Exploring the Potential Campus-Level Impact of Online Universal Sexual Assault Prevention Education.

Zapp D, Buelow R, Soutiea L, Berkowitz A, DeJong W.

J Interpers Violence. 2018 Mar 1:886260518762449. doi: 10.1177/0886260518762449. [Epub ahead of print]


The mast cell-B cell axis in lung vascular remodeling and pulmonary hypertension.

Breitling S, Hui Z, Zabini D, Hu Y, Hoffmann J, Goldenberg NM, Tabuchi A, Buelow R, Dos Santos C, Kuebler WM.

Am J Physiol Lung Cell Mol Physiol. 2017 May 1;312(5):L710-L721. doi: 10.1152/ajplung.00311.2016. Epub 2017 Feb 24.


Strategies to Obtain Diverse and Specific Human Monoclonal Antibodies From Transgenic Animals.

Brüggemann M, Osborn MJ, Ma B, Buelow R.

Transplantation. 2017 Aug;101(8):1770-1776. doi: 10.1097/TP.0000000000001702. Review.


Antigen-specific single B cell sorting and expression-cloning from immunoglobulin humanized rats: a rapid and versatile method for the generation of high affinity and discriminative human monoclonal antibodies.

Ouisse LH, Gautreau-Rolland L, Devilder MC, Osborn M, Moyon M, Visentin J, Halary F, Bruggemann M, Buelow R, Anegon I, Saulquin X.

BMC Biotechnol. 2017 Jan 9;17(1):3. doi: 10.1186/s12896-016-0322-5.


Management of Intracranial Incidental Findings on Brain MRI.

Langner S, Buelow R, Fleck S, Angermaier A, Kirsch M.

Rofo. 2016 Dec;188(12):1123-1133. Epub 2016 Jul 19. Review.


Human antibody production in transgenic animals.

Brüggemann M, Osborn MJ, Ma B, Hayre J, Avis S, Lundstrom B, Buelow R.

Arch Immunol Ther Exp (Warsz). 2015 Apr;63(2):101-8. doi: 10.1007/s00005-014-0322-x. Epub 2014 Dec 3. Review.


Efficient gene targeting by homology-directed repair in rat zygotes using TALE nucleases.

Remy S, Tesson L, Menoret S, Usal C, De Cian A, Thepenier V, Thinard R, Baron D, Charpentier M, Renaud JB, Buelow R, Cost GJ, Giovannangeli C, Fraichard A, Concordet JP, Anegon I.

Genome Res. 2014 Aug;24(8):1371-83. doi: 10.1101/gr.171538.113. Epub 2014 Jul 2.


The importance of campaign saliency as a predictor of attitude and behavior change: A pilot evaluation of social marketing campaign Fat Talk Free Week.

Garnett BR, Buelow R, Franko DL, Becker C, Rodgers RF, Austin SB.

Health Commun. 2014;29(10):984-95. doi: 10.1080/10410236.2013.827613. Epub 2013 Dec 20.


Human antibody expression in transgenic rats: comparison of chimeric IgH loci with human VH, D and JH but bearing different rat C-gene regions.

Ma B, Osborn MJ, Avis S, Ouisse LH, Ménoret S, Anegon I, Buelow R, Brüggemann M.

J Immunol Methods. 2013 Dec 31;400-401:78-86. doi: 10.1016/j.jim.2013.10.007. Epub 2013 Oct 30.


High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Igκ/Igλ loci bearing the rat CH region.

Osborn MJ, Ma B, Avis S, Binnie A, Dilley J, Yang X, Lindquist K, Ménoret S, Iscache AL, Ouisse LH, Rajpal A, Anegon I, Neuberger MS, Buelow R, Brüggemann M.

J Immunol. 2013 Feb 15;190(4):1481-90. doi: 10.4049/jimmunol.1203041. Epub 2013 Jan 9. Erratum in: J Immunol. 2013 Jun 15;190(12):6707.


Effects of BCL-2 over-expression on B cells in transgenic rats and rat hybridomas.

Iscache AL, Ménoret S, Tesson L, Rémy S, Usal C, Pedros C, Saoudi A, Buelow R, Anegon I.

Int Immunol. 2011 Oct;23(10):625-36. doi: 10.1093/intimm/dxr071. Epub 2011 Sep 19.


Characterization of immunoglobulin heavy chain knockout rats.

Ménoret S, Iscache AL, Tesson L, Rémy S, Usal C, Osborn MJ, Cost GJ, Brüggemann M, Buelow R, Anegon I.

Eur J Immunol. 2010 Oct;40(10):2932-41. doi: 10.1002/eji.201040939.


Vaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B.

Held DM, Shurtleff AC, Fields S, Green C, Fong J, Jones RG, Sesardic D, Buelow R, Burke RL.

Clin Vaccine Immunol. 2010 Jun;17(6):930-6. doi: 10.1128/CVI.00493-09. Epub 2010 Apr 21.


Generation of gene-specific mutated rats using zinc-finger nucleases.

Geurts AM, Cost GJ, Rémy S, Cui X, Tesson L, Usal C, Ménoret S, Jacob HJ, Anegon I, Buelow R.

Methods Mol Biol. 2010;597:211-25. doi: 10.1007/978-1-60327-389-3_15.


Knockout rats via embryo microinjection of zinc-finger nucleases.

Geurts AM, Cost GJ, Freyvert Y, Zeitler B, Miller JC, Choi VM, Jenkins SS, Wood A, Cui X, Meng X, Vincent A, Lam S, Michalkiewicz M, Schilling R, Foeckler J, Kalloway S, Weiler H, Ménoret S, Anegon I, Davis GD, Zhang L, Rebar EJ, Gregory PD, Urnov FD, Jacob HJ, Buelow R.

Science. 2009 Jul 24;325(5939):433. doi: 10.1126/science.1172447.


Inhibition of dendritic cell maturation and function is independent of heme oxygenase 1 but requires the activation of STAT3.

Mashreghi MF, Klemz R, Knosalla IS, Gerstmayer B, Janssen U, Buelow R, Jozkowicz A, Dulak J, Volk HD, Kotsch K.

J Immunol. 2008 Jun 15;180(12):7919-30.


The future of antibody therapy.

Buelow R, van Schooten W.

Ernst Schering Found Symp Proc. 2006;(4):83-106. Review.


Improved long-term graft survival after HO-1 induction in brain-dead donors.

Kotsch K, Francuski M, Pascher A, Klemz R, Seifert M, Mittler J, Schumacher G, Buelow R, Volk HD, Tullius SG, Neuhaus P, Pratschke J.

Am J Transplant. 2006 Mar;6(3):477-86.


Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model.

De Vry CG, Valdez M, Lazarov M, Muhr E, Buelow R, Fong T, Iyer S.

J Invest Dermatol. 2005 Sep;125(3):473-81.


Induction of carbon monoxide in the donor reduces graft immunogenicity and chronic graft deterioration.

Martins PN, Reuzel-Selke A, Jurisch A, Atrott K, Pascher A, Pratschke J, Buelow R, Neuhaus P, Volk HD, Tullius SG.

Transplant Proc. 2005 Jan-Feb;37(1):379-81.


Peritransplant treatment with cobalt protoporphyrin attenuates chronic renal allograft rejection.

Bédard EL, Jiang J, Parry N, Wang H, Liu W, Garcia B, Kim P, Chakrabarti S, Buelow R, Zhong R.

Transpl Int. 2005 Mar;18(3):341-9.


Sequence analysis of 0.4 megabases of the rabbit germline immunoglobulin kappa1 light chain locus.

Ros F, Reichenberger N, Dragicevic T, van Schooten WC, Buelow R, Platzer J.

Anim Genet. 2005 Feb;36(1):51-7.


RDP58, a novel immunomodulatory peptide, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyelitis.

DeVry CG, Valdez M, Gao L, Wang J, Kotsch K, Volk HD, Bechmann I, Buelow R, Iyer S.

J Neuroimmunol. 2004 Jul;152(1-2):33-43.


Oral RDP58 allows CPT-11 dose intensification for enhanced tumor response by decreasing gastrointestinal toxicity.

Zhao J, Huang L, Belmar N, Buelow R, Fong T.

Clin Cancer Res. 2004 Apr 15;10(8):2851-9.


Sequence analysis of 0.5 Mb of the rabbit germline immunoglobulin heavy chain locus.

Ros F, Puels J, Reichenberger N, van Schooten W, Buelow R, Platzer J.

Gene. 2004 Apr 14;330:49-59.


Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer.

Braudeau C, Bouchet D, Tesson L, Iyer S, Rémy S, Buelow R, Anegon I, Chauveau C.

Gene Ther. 2004 Apr;11(8):701-10.


Induction of heme oxygenase-1 in kidneys during ex vivo warm perfusion.

Brasile L, Buelow R, Stubenitsky BM, Kootstra G.

Transplantation. 2003 Oct 27;76(8):1145-9.


Attenuation of aortic graft arteriosclerosis by systemic administration of Allotrap peptide RDP58.

Li W, Iyer S, Lu L, Buelow R, Fung JJ, Rao AS, Woo J, Qian S.

Transpl Int. 2003 Dec;16(12):849-56. Epub 2003 Aug 27.


Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse.

Araujo JA, Meng L, Tward AD, Hancock WW, Zhai Y, Lee A, Ishikawa K, Iyer S, Buelow R, Busuttil RW, Shih DM, Lusis AJ, Kupiec-Weglinski JW.

J Immunol. 2003 Aug 1;171(3):1572-80.


RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease.

Bourreille A, Doubremelle M, de la Blétière DR, Segain JP, Toquet C, Buelow R, Galmiche JP.

Scand J Gastroenterol. 2003 May;38(5):526-32.


Generation of heme oxygenase-1-transgenic rats.

Braudeau C, Bouchet D, Toquet C, Tesson L, Ménoret S, Iyer S, Laboisse C, Willis D, Jarry A, Buelow R, Anegon I, Chauveau C.

Exp Biol Med (Maywood). 2003 May;228(5):466-71.


Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury.

Blydt-Hansen TD, Katori M, Lassman C, Ke B, Coito AJ, Iyer S, Buelow R, Ettenger R, Busuttil RW, Kupiec-Weglinski JW.

J Am Soc Nephrol. 2003 Mar;14(3):745-54.


RDP58, a locally active TNF inhibitor, is effective in the dextran sulphate mouse model of chronic colitis.

Murthy S, Flanigan A, Coppola D, Buelow R.

Inflamm Res. 2002 Nov;51(11):522-31.


RDP58, a Novel Immunomodulatory Peptide with Anti-Inflammatory Effects. A Pharmacological Study in Trinitrobenzene Sulphonic Acid Colitis and Crohn Disease.

Bourreille A, Doubremelle M, D Raingeard de la Blétière, Segain JP, Toquet C, Buelow R, Galmiche JP.

Scand J Gastroenterol. 2003;38(5):526-532. doi: 10.1080/00365520310002922.


Orally administered RDP58 reduces the severity of dextran sodium sulphate induced colitis.

Boismenu R, Chen Y, Chou K, El-Sheikh A, Buelow R.

Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii19-24.


Rational design and development of RDP58.

Iyer S, Lahana R, Buelow R.

Curr Pharm Des. 2002;8(24):2217-29. Review.


Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1.

Tullius SG, Nieminen-Kelhä M, Buelow R, Reutzel-Selke A, Martins PN, Pratschke J, Bachmann U, Lehmann M, Southard D, Iyer S, Schmidbauer G, Sawitzki B, Reinke P, Neuhaus P, Volk HD.

Transplantation. 2002 Sep 15;74(5):591-8.


Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection.

Chauveau C, Bouchet D, Roussel JC, Mathieu P, Braudeau C, Renaudin K, Tesson L, Soulillou JP, Iyer S, Buelow R, Anegon I.

Am J Transplant. 2002 Aug;2(7):581-92.


Inhibition of graft arteriosclerosis development in rat aortas following heme oxygenase-1 gene transfer.

Bouche D, Chauveau C, Roussel JC, Mathieu P, Braudeau C, Tesson L, Soulillou JP, Iyer S, Buelow R, Anegon I.

Transpl Immunol. 2002 May;9(2-4):235-8.


Heme oxygenase-1 gene transfer prevents CD95/FasL-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway.

Ke B, Shen XD, Buelow R, Melinek J, Amersi F, Gao F, Ritter T, Volk HD, Busuttil RW, Kupiec-Weglinski JW.

Transplant Proc. 2002 Aug;34(5):1465-6. No abstract available.


Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury.

Coito AJ, Buelow R, Shen XD, Amersi F, Moore C, Volk HD, Busuttil RW, Kupiec-Weglinski JW.

Transplantation. 2002 Jul 15;74(1):96-102.


Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway.

Ke B, Buelow R, Shen XD, Melinek J, Amersi F, Gao F, Ritter T, Volk HD, Busuttil RW, Kupiec-Weglinski JW.

Hum Gene Ther. 2002 Jul 1;13(10):1189-99.


Protection of grafts by hemoxygenase-1 and its toxic product carbon monoxide.

Buelow R, Tullius SG, Volk HD.

Am J Transplant. 2001 Nov;1(4):313-5. Review. No abstract available.


Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation.

Kato H, Amersi F, Buelow R, Melinek J, Coito AJ, Ke B, Busuttil RW, Kupiec-Weglinski JW.

Am J Transplant. 2001 Jul;1(2):121-8.


Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway.

Amersi F, Shen XD, Anselmo D, Melinek J, Iyer S, Southard DJ, Katori M, Volk HD, Busuttil RW, Buelow R, Kupiec-Weglinski JW.

Hepatology. 2002 Apr;35(4):815-23.


Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway.

Katori M, Buelow R, Ke B, Ma J, Coito AJ, Iyer S, Southard D, Busuttil RW, Kupiec-Weglinski JW.

Transplantation. 2002 Jan 27;73(2):287-92.


Supplemental Content

Loading ...
Support Center